Muestra la distribución de su producción desde 2008 por disciplinas.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Institución | Advanced Center for Chronic Diseases |
| WOS | #Pub |
|---|---|
| Pharmacology & Pharmacy | 6 |
| Medicine, General & Internal | 6 |
| Chemistry, Multidisciplinary | 3 |
| Biology | 3 |
| Nanoscience & Nanotechnology | 2 |
| Materials Science, Multidisciplinary | 2 |
| Physics, Applied | 2 |
| Multidisciplinary Sciences | 2 |
| Cell Biology | 2 |
| Respiratory System | 2 |
| Neurosciences | 2 |
| Public, Environmental & Occupational Health | 2 |
| Cardiac & Cardiovascular Systems | 2 |
| Pediatrics | 1 |
| Infectious Diseases | 1 |
| Medicine, Research & Experimental | 1 |
| Biotechnology & Applied Microbiology | 1 |
| Oncology | 1 |
| Energy & Fuels | 1 |
| Anatomy & Morphology | 1 |
| Materials Science, Biomaterials | 1 |
| Scopus | #Pub |
|---|---|
| Medicine (All) | 3 |
| Chemistry (All) | 2 |
| Pharmaceutical Science | 2 |
| Condensed Matter Physics | 2 |
| Agricultural And Biological Sciences (All) | 2 |
| Biochemistry, Genetics And Molecular Biology (All) | 2 |
| Biochemistry | 1 |
| Drug Discovery | 1 |
| Mechanical Engineering | 1 |
| Microbiology (Medical) | 1 |
| Pharmacology, Toxicology And Pharmaceutics (All) | 1 |
| Microbiology | 1 |
| Pharmacology (Medical) | 1 |
| Pediatrics, Perinatology And Child Health | 1 |
| Renewable Energy, Sustainability And The Environment | 1 |
| Pharmacology | 1 |
| Mechanics Of Materials | 1 |
| Electronic, Optical And Magnetic Materials | 1 |
| Materials Science (All) | 1 |
| Electrical And Electronic Engineering | 1 |
| Infectious Diseases | 1 |
| SciELO | #Pub |
|---|---|
| Health Sciences | 8 |
| Biological Sciences | 2 |
| Exact And Earth Sciences | 2 |
| Publicaciones | Citas | ||||
|---|---|---|---|---|---|
| Total | Porcentaje | Total | Porcentaje | Representativas Cuartil (Mediana) | |
| Q1 | 12 | 57.1 % | 1217 | 93.5 % | 8.5 |
| Q2 | 5 | 23.8 % | 52 | 4.0 % | 9 |
| Q3 | 0 | 0.0 % | 0 | 0.0 % | |
| Q4 | 4 | 19.0 % | 33 | 2.5 % | 7.5 |